Haisen Pharm: Net profit of 60.7942 million yuan in the first half of 2025, a year-on-year increase of 4.74%
Haisen Pharm announced that in the first half of 2025, operating revenue was 242 million yuan, a year-on-year increase of 14.93%; net profit was 60.7942 million yuan, a year-on-year increase of 4.74%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments